Literature DB >> 9437190

Deficiency of cholesteryl ester transfer protein. Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma.

A Ritsch1, H Drexel, F W Amann, C Pfeifhofer, J R Patsch.   

Abstract

A patient is described who exhibited, despite excessively high postprandial triglyceride levels, high levels of HDL cholesterol. Measurement of CETP activity and mass in the patient's plasma showed values of less than 5% and 2%, respectively, of a normolipidemic plasma pool. The CETP cDNA of the patient exhibited a mutation (T-->G), turning codon 57 (TAT) of exon 2 into a stop codon (TAG) and abolishing a, XcmI restriction site. Digestion of directly amplified CETP cDNA from the patient with XcmI indicated the exclusive presence of CETP cDNA containing the mutation. Analysis of the corresponding region of the CETP gene indicated the patient to be heterozygous for the nonsense mutation at codon 57, a finding that can only be explained by the presence of a null allele in addition to the allele with the nonsense mutation. The combination of TG intolerance of uncertain cause, together with CETP deficiency due to a novel mutation, produced the paradoxical constellation--high levels of HDL cholesterol (172 mg/dL) associated with a high post-prandial lipemia of 1460 mg triglycerides/dL.8 hours--and provided further insight into the role of CETP as mediator between pools of triglycerides and cholesteryl esters in plasma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9437190     DOI: 10.1161/01.atv.17.12.3433

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

Review 3.  Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.

Authors:  Philip J Barter; Kerry-Anne Rye
Journal:  J Lipid Res       Date:  2012-05-22       Impact factor: 5.922

Review 4.  Cholesteryl ester transfer protein and its inhibitors.

Authors:  Sudichhya Shrestha; Ben J Wu; Liam Guiney; Philip J Barter; Kerry-Anne Rye
Journal:  J Lipid Res       Date:  2018-02-27       Impact factor: 5.922

5.  A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-cholesterol in adult asymptomatic women.

Authors:  Eliane S Parra; Aline Urban; Natalia B Panzoldo; Rui T Nakamura; Rogério Oliveira; Eliana C de Faria
Journal:  Lipids Health Dis       Date:  2011-05-24       Impact factor: 3.876

Review 6.  Unique features of high-density lipoproteins in the Japanese: in population and in genetic factors.

Authors:  Shinji Yokoyama
Journal:  Nutrients       Date:  2015-04-02       Impact factor: 5.717

Review 7.  Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP.

Authors:  Shinji Yokoyama; Kuniko Okumura-Noji; Rui Lu
Journal:  J Biomed Res       Date:  2015-04-15

Review 8.  HDL Receptor in Schistosoma japonicum Mediating Egg Embryonation: Potential Molecular Basis for High Prevalence of Cholesteryl Ester Transfer Protein Deficiency in East Asia.

Authors:  Shinji Yokoyama
Journal:  Front Cell Dev Biol       Date:  2022-03-17

9.  An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway.

Authors:  James Lu; Katrin Hübner; M Nazeem Nanjee; Eliot A Brinton; Norman A Mazer
Journal:  PLoS Comput Biol       Date:  2014-03-13       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.